tbuckley/cabot-search huggingface dataset:
DNA methylation and transcriptomic alterations define distinct groups in pediatric spinal ependymoma
Authors: Omar Ahmad, Rebecca Chapman, Lisa Storer, Li Luo, Linda Resar, Kenneth Cohen, Richard Grundy, Anbarasu Lourdusamy
Journal: Neuro-Oncology (2019)

Abstract In contrast, compared to adults, spinal ependymomas (SEPN) are less common in childhood and adolescents. Children with these tumours are likely to experience a more aggressive disease course, with a higher rate of local failure, and a higher rate of metastasis. Presently the molecular basis of SEPN is poorly characterized. Therefore, we have analyzed 29 SEPN tumour samples from pediatric patients (female: 11, male: 15; age range: 4 – 21 years) and performed DNA methylation (n=28) and transcriptome profiling (n=29). Unsupervised analysis of methylation data reliably separated these tumours into two distinct groups: one group covering all myxopapillary ependymomas (MPE) and a second group dominated by grade II SPENs (SP-EPN). We identified 242 differentially methylated regions between these two groups, of which 56% showed high methylation levels in MPE, including 22 regions localized on chromosome 6. Genome-wide copy number analysis using methylation data showed differences in numbers and pattern of DNA copy number alterations between these groups. Gain of chromosome 20 (39%) followed by loss of chromosomes 6 (28%), 10 (28%), and 13 (28%) were detected in the MPE group, whereas loss of chromosome 22 was frequent (60%) in the SP-EPN group. Transcriptomic analysis showed that genes associated with oxidative phosphorylation, TCA cycle components, electron transport, and Interferon-gamma production characterize the MPE group whereas potassium ion import and regulation of astrocyte differentiation characterize the SP-EPN group. Taken together, this data suggest that mitochondrial oxidative phosphorylation may drive the regulation of energy metabolism of MPE tumours.
Phase 1 Study of TRU-016, An Anti-CD37 SMIP™ Protein in Relapsed and/or Refractory NHL Patients
Authors: John M. Pagel, Stephen Spurgeon, Farrukh Awan, Kristie A. Blum, Mark C Lanasa, Ian W. Flinn, Scott Stromatt, John C. Byrd, Ajay K. Gopal
Journal: Blood (2011)
Bafilomycin A1 Targets Both Autophagy and Apoptosis Pathways in Pediatric t(1;19) Pre-B Acute Lymphoblastic Leukemia Cells
Authors: Na Yuan, Lin Song, Suping Zhang, Weiwei Lin, Yan Cao, Fei Xu, Yixuan Fang, Zheng Wang, Zhijian Wang, Xin Li, Jinyang Cai, Yi Zhang, Wenli Zhao, Shaoyan Hu, Suning Chen, Xinliang Mao, Jianrong Wang
Journal: Blood (2014)
Successful Control of Preexistent Active Infection by Granulocyte Transfusions During Conditioning Induced Cytopenia In Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Stem Cell Transplant
Authors: P. Dayand Borge, Narda Theobald, Rosamma DeCastro, Harry L. Malech, Susan Leitman, Elizabeth M. Kang
Journal: Blood (2010)
Experience of lenvatinib therapy for patients with differentiated thyroid cancer in our hospital
Authors: Keisuke Miwa, Masaru Fukahori, Toshimitsu Tanaka, Sachiko Nagasu, Tomoyuki Ushijima, Kouta Shigetou, Takeharu Ono, Hirohito Umeno, Takuji Torimura, Yoshito Akagi
Journal: Annals of Oncology (2019)
Prospective, Multicenter Phase I–II Pilot Trial to Evaluate Efficacy and Safety of Lenalidomide Plus Rituximab-CHOP21 (LR-CHOP21) for Elderly Patients with Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Interim Analysis of the Intergruppo Italiano Linfomi (IIL) REAL07 Study
Authors: Umberto Vitolo, Annalisa Chiappella, Angelo Michele Carella, Ileana Baldi, Giovannino Ciccone, Angela Congiu, Gianluca Gaidano, Pasqualina De Masi, Marco Ladetto, Alessandro Levis, Anna Marina Liberati, Lorella Orsucci, Vincenzo Pavone, Sonia Perticone, Alessandra Tucci, Manuela Zanni, Giuseppe Rossi
Journal: Blood (2010)
Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)
Authors: Ann M. Leen, Catherine M Bollard, Adam M Mendizabal, Elizabeth J. Shpall, Paul Szabolcs, Joseph H. Antin, Neena Kapoor, Callie Heaton, Bambi J Grilley, Adrian P. Gee, Malcolm K. Brenner, Cliona M Rooney, Helen E. Heslop
Journal: Blood (2010)
A Phase II Study of Lenalidomide for Previously Untreated Deletion (del) 5q Acute Myeloid Leukemia (AML) Patients Age 60 or Older Who Are Not Candidates for Remission Induction Chemotherapy (Southwest Oncology Group Study S0605)
Authors: Mikkael A. Sekeres, Holly Gundacker, Jeffrey Lancet, Anjali Advani, Stephen Petersdorf, Jane L. Liesveld, Deborah Mulford, Tom Norwood, Cheryl L. Willman, Alan F. List, Frederick R. Appelbaum
Journal: Blood (2010)
Bone Marrow Failure and Developmental Delay Caused By Mutations in Poly(A)-Specific Ribonuclease
Authors: Santhosh Dhanraj, Sethu Madhava Rao Gunja, Adam P Deveau, Mikael Nissbeck, Boonchai Boonyawat, Andrew J Coombs, Alessandra Renieri, Mafalda Mucciolo, Annabella Marozza, Sabrina Buoni, Lesley Turner, Hongbing Li, Ameer Jarrar, Mathura Sabanayagam, Melanie Kirby, Mary Shago, Dalila Pinto, Jason N. Berman, Stephen W. Scherer, Anders Virtanen, Yigal Dror
Journal: Blood (2015)
Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Light-Chain MGUS (LCMGUS) In a Metropolitan Area In Germany
Authors: Lewin Eisele, Jan Dürig, Andreas Huttmann, Ulrich Dührsen, Anja Führer, Sabrina Kieruzel, Roland Assert, Beate Bokhof, Raimund Erbel, Klaus Mann, Karl-Heinz Jöckel, Susanne Moebus
Journal: Blood (2010)
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country
Authors: Ana C Glembotsky, Rosana F Marta, Yesica R Espasandin, Nora P Goette, Fernando Negro, Noris Patrizia, Anna Savoia, Alessandro Pecci, Carlo Luigi Balduini, Felisa C. Molinas, Paula G Heller
Journal: Blood (2011)
Proteomic Analysis of Soluble Proteins Important in Pediatric Acute Lymphoblastic Leukemia.
Authors: Martin Kovac, Denisa Petrackova, Vendula Pelkova, Martina Vaskova, Ester Mejstrikova, Tomas Kalina, Petra Volna, Silvie Bezouskova, Jaroslav Weiser, Ondrej Hrusak
Journal: Blood (2009)
Intensive Treatment Strategies May Not Provide Superior Outcomes in Mantle Cell Lymphoma: Overall Survival Exceeding Seven Years in a Large Cohort of Patients Managed Primarily with Conservative Therapies.
Authors: Peter Martin, Amy Chadburn, Paul Christos, Richard R. Furman, Jia Ruan, Maureen A. Joyce, Patricia Glynn, Ruben Niesvizky, Eric J. Feldman, Tsiporah B. Shore, Michael W. Schuster, Scott Ely, Daniel Knowles, Selina Chen-Kiang, Morton Coleman, John P. Leonard
Journal: Blood (2007)
Air Pollution, Clustering of Particulate Matter Components, and Breast Cancer in the Sister Study: A U.S.-Wide Cohort
Authors: Alexandra J. White, Joshua P. Keller, Shanshan Zhao, Rachel Carroll, Joel D. Kaufman, Dale P. Sandler
Journal: Environmental Health Perspectives (2019)

Particulate matter (PM) is a complex mixture. Geographic variations in PM may explain the lack of consistent associations with breast cancer.We aimed to evaluate the relationship between air pollution, PM components, and breast cancer risk in a United States-wide prospective cohort.We estimated annual average ambient residential levels of particulate matter <2.5 μm and <10 μm in aerodynamic diameter (PM2.5 and PM10, respectively) and nitrogen dioxide (NO2) using land-use regression for 47,433 Sister Study participants (breast cancer-free women with a sister with breast cancer) living in the contiguous United States. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for risk associated with an interquartile range (IQR) increase in pollutants. Predictive k-means were used to assign participants to clusters derived from PM2.5 component profiles to evaluate the impact of heterogeneity in the PM2.5 mixture. For PM2.5, we investigated effect measure modification by component cluster membership and by geographic region without regard to air pollution mixture.During follow-up (mean=8.4 y), 2,225 invasive and 623 ductal carcinoma in situ (DCIS) cases were identified. PM2.5 and NO2 were associated with breast cancer overall [HR=1.05 (95% CI:0.99, 1.11) and 1.06 (95% CI:1.02, 1.11), respectively] and with DCIS but not with invasive cancer. Invasive breast cancer was associated with PM2.5 only in the Western United States [HR=1.14 (95% CI:1.02, 1.27)] and NO2 only in the Southern United States [HR=1.16 (95% CI:1.01, 1.33)]. PM2.5 was associated with a higher risk of invasive breast cancer among two of seven identified composition-based clusters. A higher risk was observed [HR=1.25 (95% CI: 0.97, 1.60)] in a California-based cluster characterized by low S and high Na and nitrate (NO3-) fractions and for another Western United States cluster [HR=1.60 (95% CI: 0.90, 2.85)], characterized by high fractions of Si, Ca, K, and Al.Air pollution measures were related to both invasive breast cancer and DCIS within certain geographic regions and PM component clusters. https://doi.org/10.1289/EHP5131.
Environmental factors associated with allergy in urban and rural children from the South African Food Allergy (SAFFA) cohort
Authors: Michael E. Levin, Maresa Botha, Wisdom Basera, Heidi E. Facey-Thomas, Ben Gaunt, Claudia L. Gray, Wanjiku Kiragu, Jordache Ramjith, Alexandra Watkins, Jon Genuneit
Journal: Journal of Allergy and Clinical Immunology (2019)
Febrile Neutropenia Risk Assessment and Granulocyte-Colony Stimulating Factor Support in Patients with Diffuse Large B Cell Lymphoma Receiving R-CHOP Regimens.
Authors: Antonio Salar, Corinne Haioun, Francesca Gaia Rossi, Ulrich Duehrsen, Ruth Pettengell, Hans Erik Johnsen, Ulrich Jaeger, Gregor Verhoef, Matthias Schwenkglenks, Fernando Principe, Pamela Bacon, Kate Bendall, P.J. Lugtenburg
Journal: Blood (2009)
Notice of Retraction. Aboumatar et al. Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial. <i>JAMA</i>. 2018;320(22):2335-2343.
Authors: Hanan Aboumatar, Robert A. Wise
Journal: JAMA (2019)

Our experience with disease comorbidity analysis shows that time-ordered disease comorbidity relationships offer important insights on patient outcomes.Furthermore, these progression studies often reveal the association between seemingly unrelated diagnoses and the major diagnoses highlighted by indices such as the Elixhauser comorbidity index.Using this approach, our research group built temporal comorbidity trajectories to examine disease associations in an entire population. 3 When applied to the single diagnosis of sepsis, this approach gave important information on outcome, even when the details of the sepsis hospitalization were not available. 4 In addition, machine learning techniques can help create dynamic comorbidity indices that evolve with changes in patient outcomes.A neural network approach combined highfrequency clinical data from intensive care unit hospitalizations with 20-year disease comorbidity trajectories to predict outcome in individual patients in the intensive care unit. 5 In this case, especially for sepsis, the analysis of comorbidities was a far better predictor of outcome than previously used methods and the addition of acute physiology measures added to the predictive value.We do not know the effect such a disease comorbidity analysis could have on the results of the study by Dr Seymour and colleagues. 1 We suggest that understanding the phenotype of critically ill patients should include a more thorough accounting of the medical history than can be obtained through commonly used comorbidity indices in addition to highfrequency clinical measures and laboratory analyses.
Clinical and Biological Role of Accumulation of the NPM-1 Splice Variant R2 in AML, MDS and sAML
Authors: Grazyna Stasiak, Malgorzata Zajac, Joanna Zaleska, Michal Kielbus, Jakub Czapinski, Andrzej Stepulak, Olga Jankowska-Lecka, Tomasz Gromek, Norbert Grzasko, Maria Soroka-Wojtaszko, Aneta Szudy-Szczyrek, Bozena Sokolowska, Marek Hus, Lars Bullinger, Krzysztof Giannopoulos
Journal: Blood (2016)
Very High Efficiency of ICE (Ifosfamide-Carboplatin-Etoposide) in Relapse/Refractory (R/R) Primary Central Nervous System (PCNSL) and Vitreo-Retinal (VRL) Non Hodgkin Lymphoma. a LOC Network Multicenter Retrospective Study on 58 Cases
Authors: Sylvain Choquet, Adrien Grenier, Caroline Houillier, Carole Soussain, Marie Pierre Moles, Thomas Gastinne, Nathalie Cassoux, Helene merle Beral, Damien roos Weil, Veronique Leblond, Khe hoang Xuan
Journal: Blood (2015)
Explanation of Additional Errors in Report of Trial of Low-Dose, Low-Frequency Oral Psoralen–UV-A Treatment
Authors: Peter Wolf, Pablo Vieyra-Garcia
Journal: JAMA Dermatology (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Dermatology journal
The Number of CD4+ T-Lymphocytes in the Autograft Correlates with Outcome After Autologous Stem-Cell Transplantation in Relapsed Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
Authors: Rony Schaffel, Maria L.S. Lima, Adrienne B.M. Madureira, Nelson Spector, Helio S. Dutra
Journal: Blood (2009)
The Synergistic Effect of DNA Methylation Inhibitor 5-Azacytidine and Bcl-2 Signaling Blockade ABT-737 Combination Treatment Induce Apoptosis In AML
Authors: Yuexi Shi, Twee Tsao, Hongbo Lu, Sergej Konoplev, Wendy D. Schober, Michael Andreeff, Marina Konopleva
Journal: Blood (2010)
Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma
Authors: Paula Scotland, Philippe Gaulard, Cassandra L Love, Virginie Fataccioli, Marion Travert, Laurence De Leval, Dennis D. Weisenburger, Magdalena Czader, Mayur Parihar, Reena Nair, Manju Sengar, Anne W Beaven, Jennifer H. Crow, Rodney R. Miles, Leo I. Gordon, Amy Chadburn, Andrew M Evens, Javed Gill, Yuri D. Fedoriw, Kristy L. Richards, Gopesh Srivastava, William W. L. Choi, Christopher R. Flowers, Leon Bernal-Mizrachi, Karen P. Mann, Kikkeri Naresh, Eric D. Hsi, Pedro Horna, Jianguo Tao, Zhen Sun, Kevin Long, Jenny Zhang, Sandeep Dave
Journal: Blood (2013)
A multicenter retrospective study of GEM+nab-PTX or FOLFIRINOX in metastatic pancreatic cancer patients: NAPOLEON study
Authors: Yujiro Ueda, Taiga Otsuka, Mototsugu Shimokawa, Futa Koga, Junichi Nakazawa, Satoshi Ootsu, Shiho Arima, Masaru Fukahori, Akitaka Makiyama, Hiroki Taguchi, Takuya Honda, Taro Shibuki, Tsuyoshi Shirakawa, Kenji Mitsugi, Kenta Nio, Yasushi Ide, Norio Ureshino
Journal: Annals of Oncology (2019)
Interleukin-12 Gene Expression into Acute Myeloid Leukemia-Derived Dendritic Cells Overcomes T-Cell Functional Impairment Induced by Leukemic Microenvironment.
Authors: Antonio Curti, Simona Pandolfi, Michela Aluigi, Alessandro Isidori, Isabella Alessandrini, Claudia Chiodoni, Nicoletta Testoni, Mario P. Colombo, Michele Baccarani, Roberto M. Lemoli
Journal: Blood (2004)
Y-90 Ibritumomab Tiuxetan as Consolidation Following Three Cycles of Fludarabine-Cyclophosphamide-Rituximab Chemoimmunotherapy in Patients with Relapsed Follicular, Indolent or Mantle-Cell Lymphoma: A Prospective “Dose”-Finding Study.
Authors: Christoph von Schilling, Kathleen Schwarz, Georg Hess, Andreas Viardot, Michael Sandherr, Stefan Krause, Jan P. Simon, Nadine Roethling, Christian Peschel, Markus Schwaiger, Klemens Scheidhauer
Journal: Blood (2007)
Aggressive Chemotherapy (CHOEP-14) and Rituximab or High-Dose Therapy (MegaCHOEP) and Rituximab for Young, High-Risk Patients with Aggressive B-Cell Lymphoma: Results of the MegaCHOEP Trial of the German High — Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Authors: Norbert Schmitz, Maike Nickelsen, Marita Ziepert, Matthias Haenel, Peter Borchmann, Andreas Viardot, Christina Nickenig, Martin Bentz, Christian Peschel, Lorenz Trümper, Markus Loeffler, Michael Pfreundschuh, Bertram Glass
Journal: Blood (2009)
Ferumoxytol Treatment Results in Robust Hemoglobin Increases in Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy in a Phase III, Randomized, Placebo-Controlled Trial.
Authors: Saroj Vadhan Raj, Michael Cressman, David Ford, William Strauss, Gerri Poss, Kristine Bernard, Zhu Li, Lee F. Allen
Journal: Blood (2012)
The Pharmacological Inhibition of KDM1A Displays Preclinical Efficacy in AML and MDS By Inducing Myelomonocytic Differentiation
Authors: Noriko Sugino, Masahiro Kawahara, Takayoshi Suzuki, Yuya Nagai, Yayoi Shimazu, Sumie Fujii, Ryusuke Yamamoto, Masakatsu Hishizawa, Akifumi Takaori-Kondo
Journal: Blood (2014)
Interim Analysis of a Pan European Stop Tyrosine Kinase Inhibitor Trial in Chronic Myeloid Leukemia : The EURO-SKI study
Authors: Francois-Xavier Mahon, Johan Richter, Joelle Guilhot, Martin C Muller, Christian Dietz, Kimmo Porkka, Henrik Hjorth-Hansen, Franz Gruber, Panos Panagoitidis, Gert J Ossenkoppele, Jiri Mayer, Antonio Almeida, Katerina Machova Polakova, Hans Ehrencrona, Veli Kairisto, Marc G Berger, Ulla Olsson stromberg, Satu Mustjoki, Andreas Hochhaus, Markus Pfirrmann, Susanne Saussele
Journal: Blood (2014)
Derangements of Toll-like Receptors, Inflammatory Cytokines, and Reactive Oxygen Species in Philadelphia Chromosome-Negative Myeloproliferative Neoplasm: Implicate Roles of Inflammation in the Pathogenesis
Authors: Guanfang Shi, Hui Chen, Cherif Abdelmalek, Andrei Bandarchuk, Abdullah Khawer Mahmood, Wong Ching, Madhumati Kalavar, Vladimir Gotlieb, Tony W. Cheung, Jen-Chin Wang
Journal: Blood (2016)
Discovery of Unique Biomarkers That Predict Bortezomib-Induced Peripheral Neuropathy: The Results of a Multicenter Prospective Clinical Study of Multiple Myeloma in Japan
Authors: Takashi Watanabe, Masato Mitsuhashi, Morihiko Sagawa, Kenshi Suzuki, Masaki Ri, Masahiro Abe, Ken Ohmachi, Yasunori Nakagawa, Shingen Nakamura, Mizuki Chosa, Shinsuke Iida, Masahiro Kizaki
Journal: Blood (2012)
The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms
Authors: Pritesh R. Patel, Vitalyi Senyuk, Elisa Bonetti, Dolores Mahmud, Shrihari S. Kadkol, Annie L. Oh, Nadim Mahmud, Damiano Rondelli
Journal: Blood (2016)
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients
Authors: Cristina Papayannidis, Viviana Guadagnuolo, Ilaria Iacobucci, Sandra Durante, Carolina Terragna, Emanuela Ottaviani, Maria Chiara Abbenante, Federica Cattina, Simona Soverini, Barbara Lama, Lucia Toni, Wendy J. Levin, Rachel Courtney, Carmen Baldazzi, Antonio Curti, Michele Baccarani, Catriona Jamieson, Jorge E. Cortes, Vivian Oehler, Karen McLachlan, Todd Van Arsdale, Giovanni Martinelli
Journal: Blood (2011)
Pharmacokinetics and Pharmacodynamics of CNTO 528, a Novel Erythropoietin Receptor Agonist in Normal and Anemic Rats.
Authors: Peter Bugelski, T. Nesspor, T. Spinka-Doms, D. Makropoulos, E. Eirikis, J. Fisher, A. Volk, K. Shamberger, I. James, P. Fisher, C. Pool, H. Jang, B. Miller, C. Huang, G. Heavner, D. Knight, J. Ghrayeb, B. Scallon
Journal: Blood (2005)
Molecular Mechanisms Regulating Resistance to the Akt Inhibitor Perifosine in Waldenstrom’s Macroglobulinemia, the Role of the ERK and PKC Pathways.
Authors: Xavier Leleu, Hai Ngo, Xiaoying Jia, Anne-Sophie Moreau, Evdoxia Hatjiharisi, Ruben Carrasco, Garrett O’Sullivan, Judith Runnels, Yu-Tsu Tai, Steven Treon, Teru Hideshima, Kenneth Anderson, Irene Ghobrial
Journal: Blood (2006)
ABC and GCB DLBCLs Display Unique Biologically Distinct and Clinically Relevant Epigenetic Signatures.
Authors: Rita Shaknovich, Huimin Geng, Nathalie Johnson, Leandro Cerchietti, Maria E Figueroa, Lucas Tsikitas, Olivier Elemento, Joseph M. Connors, Laurie Sehn, Randy D. Gascoyne, Ari Melnick
Journal: Blood (2009)
Self-Renewal and Differentiation in Hematopoietic Stem and Progenitor Cells Is Controlled By the APC/C Coactivator Cdh1
Authors: Daniel Ewerth, Stefanie Kreutmair, Birgit Kügelgen, Dagmar Wider, Julia Felthaus, Julia Schüler, Andrea Schmidts, Justus Duyster, Anna Lena Illert, Monika Engelhardt, Ralph Wäsch
Journal: Blood (2015)
Inhibition of AKT Signaling Potently Inhibits the Growth of JAK and MPL-Mutant Cells in the Myeloproliferative Neoplasms In Vitro and In Vivo,
Authors: Irum Khan, Zan Huang, Qiang Jeremy Wen, Priya Koppikar, Ross L Levine, Ayalew Tefferi, John Crispino
Journal: Blood (2011)
­Selective Inhibitor of Nuclear Export (SINE), Selinexor (KPT-330), Shows Remarkable Activity Against AML Leukemia-Initiating Cells
Authors: Julia Etchin, Bonnie Thi Le, Alex Kentsis, Marc R Mansour, Alla Berezovskaya, Richard M. Stone, Ilene Galinsky, Daniel J. DeAngelo, Dilara McCauley, Michael Kauffman, Sharon Shacham, Jean C.Y. Wang, Andrew L Kung, A. Thomas Look
Journal: Blood (2014)
Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated Antigen-Specific CD8+ T Cells.
Authors: J. Joseph Melenhorst, Phillip Scheinberg, Emma Gostick, Pratip K. Chattopadhyay, Anna Lissina, David K. Cole, Mario Roederer, Ethan Bornstein, Nancy F. Hensel, Daniel C. Douek, Andrew K. Sewell, A. John Barrett, David A. Price
Journal: Blood (2007)
Early Discontinuation of Lenalidomide in Patients with Relapsing or Refractory Multiple Myeloma: Predictive Factors for Stopping in the Real Life
Authors: Aureliano Pistone, Marie Maerevoet, Sebastian Wittnebel, Marie Vercruyssen, Chloé Spilleboudt, Sarah Buntinx, Dominique Bron, Nathalie Meuleman
Journal: Blood (2016)
A Multicenter, Single-Arm, Open-Label Study To Evaluate the Efficacy and Safety of Single-Agent Lenalidomide in Patients with Relapsed and Refractory Multiple Myeloma; Prelininary Results.
Authors: Paul Richardson, Sundar Jagannath, Mohamad Hussein, James Berenson, Seema Singhal, David Irwin, Stephanie F. Williams, William Bensinger, Ashraf Z. Badros, Robert Vescio, Laurie Kenvin, Zhinuan Yu, Marta Olesnyckyj, Herbert Faleck, Jerome Zeldis, Robert Knight, Kenneth C. Anderson
Journal: Blood (2005)
Clinical Significance of CD33 Non-Synonymous Single Nucleotide Polymorphisms (SNPs) in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab Ozogamicin-Containing Chemotherapy,
Authors: Jatinder Lamba, Leslie J. Mortland, Amit Mitra, Roland B. Walter, Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, Betsy A. Hirsch, Susana C. Raimondi, Janet Franklin, Soheil Meshinchi
Journal: Blood (2011)
Tissue Factor (TF) Activation by Antithymocyte Globulin Is Inhibited by a Novel Monoclonal Antibody Specific for Reduced TF Mutated at the Allosteric Cys186-Cys209 Disulfide.
Authors: Florian Langer, Brigitte Spath, Francis Ayuketang Ayuk, Nicolaus Kroeger, Barbara Eifrig, Carsten Bokemeyer, Wolfram Ruf
Journal: Blood (2010)
Reinvestigation of the T-Cell Inactivation Achieved for the Prevention of TA GV HD By 2500 Gy of Gamma Irradiation, a Comparison with Pathogen Reduction
Authors: Patricia A Merkel, Hannah E Giclas, Andrew Gibula, Gillian Andersen, Vijaya Knight, Jin-Sying Lin, Grace Castro, Jennifer Green, Adonis Stassinopoulos
Journal: Blood (2016)